A 66-year-old patient with ST-segment elevation myocardial infarction and multivessel coronary artery disease has had the culprit lesion successfully treated. The team is planning complete coronary-artery revascularization and is considering how to identify nonculprit lesions that warrant treatment.
What does the evidence in this abstract support for this patient population?
